Drug Testing Locations - East Honolulu, HI

Drug Testing in East Honolulu, HI

East Honolulu, Hawaii Statistics

East Honolulu in Honolulu County recorded a 15% increase in drug-related crimes in 2022.

In Honolulu County, opioid-related hospital visits increased by 27% over the last five years.

The percentage of young adults in Honolulu County using marijuana rose by 8% from 2018 to 2022.

Methamphetamine remains the most commonly abused drug in East Honolulu, as of 2023.

Honolulu County reports a 5% annual increase in drug rehabilitation admissions as of 2023.

East Honolulu saw a 12% decline in teen drug use due to local prevention programs in 2022.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in East Honolulu, HI & Drug Testing Policies

Employers in East Honolulu, recognizing the impact of drug abuse on the workforce, have implemented comprehensive drug testing policies. Routine pre-employment drug screenings are standard, as well as random testing post-employment to maintain a drug-free workplace. Companies partner with organizations like the Hawaii Employers Council for policy guidance.

Local businesses often provide access to Employee Assistance Programs (EAPs), promoting rehabilitation while ensuring confidentiality. These employers consider it not only a legal responsibility but also a communal one, to uphold a healthy working environment and protect the safety of their employees and clients.

Government Efforts with Drug Problems in East Honolulu, HI

The government of East Honolulu, in collaboration with Honolulu County, has been actively addressing drug issues through several programs. The Honolulu CARES Program provides critical resources and support for those affected by substance abuse. Additionally, Hawaii's state government's Department of Health runs preventive initiatives tailored to curbing drug use through awareness and education.

Moreover, federal agencies, like the Substance Abuse and Mental Health Services Administration (SAMHSA), work in tandem with local entities to ensure the availability of grants and resources. Law enforcement efforts are bolstered by the Drug Enforcement Administration (DEA), implementing measures to curtail drug trafficking and distribution in the region.

Local Drug Busts & News in East Honolulu, HI

East Honolulu has seen various successful drug busts over the past several years, reflecting ongoing efforts by local law enforcement. For instance, in March 2023, a major operation led to the seizure of over 50 pounds of methamphetamine in the region, significantly reducing local supply. These busts have largely contributed to the dismantling of drug trafficking networks.

Moreover, the community in Honolulu County actively organizes drug awareness forums, enabling residents to gain insight and support against the threats of substance abuse. These events foster a community of vigilance and cooperation, encouraging residents to report suspicious activities and volunteer in awareness programs.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in East Honolulu, HI. Trusted by employers nationwide for accurate results and exceptional service.

Hawaii DOT/Non DOT Physicals

Hawaii Vision Tests

Hawaii Audiograms

Hawaii Respirator Fit Tests

Hawaii Lift Tests

Hawaii Background Checks

Clinical Testing Services

TB Testing in HI

Diabetes Testing in HI

Infectious Disease Testing in HI

Sickle Cell Anemia Testing in HI

Women/Men's Health Testing in HI

Resources & Citations

Hawaii o-drug Initiative

Hawaii Dept of Health Substance Abuse

SAMHSA

Maui Health Behavioral Services

Habilitat Hawaii

Hawaii Addiction Treatment

Hawaii Health & Harm Reduction Center

Aloha Medical Mission

Drug Testing Near East Honolulu, HI

Halawa, HI

Kahalu?u, HI

Kahaluu, HI

Ahuimanu, HI

Heeia, HI

He?eia, HI

Kaneohe Station, HI

Kaneohe, HI

Honolulu, HI

Koolaupoko, HI

Urban Honolulu, HI

Maunawili, HI

Waimanalo, HI

Waimanalo Beach, HI

Frequently Asked Questions

Customer Reviews